Table 1.
Baseline characteristics of 68 subjects included in the study stratified by FFRCT results.
| FFRCT ≤0.80 n = 40 | FFRCT >0.80 n = 28 | p value | |
|---|---|---|---|
| Age - mean ± SD, years | 57.1 ± 7.2 | 53.9 ± 9.7 | 0.154 |
| Female gender - no. (%) | 6 (15.0) | 14 (50.0) | 0.003 |
| Cardiovascular Risk factors - no. (%) | |||
| Hypertension | 24 (60.0) | 17 (60.7) | 1.000 |
| Diabetes mellitus | 11 (27.5) | 5 (17.9) | 0.400 |
| Dyslipidemia | 24 (60.0) | 18 (64.3) | 0.803 |
| Family history of premature CAD | 8 (20.0) | 11 (39.3) | 0.103 |
| Former or current smoker | 28 (70.0) | 14 (50.0) | 0.129 |
| Obesity (BMI ≥30 kg/m2) | 18 (45.0) | 12 (42.9) | 1.000 |
| Medications | |||
| Aspirin | 13 (32.5) | 8 (28.6) | 0.794 |
| Beta-blockers | 9 (22.5) | 9 (32.1) | 0.413 |
| ACE inhibitors/ARB | 14 (35.0) | 9 (32.1) | 1.000 |
| Calcium channel blocker | 5 (12.5) | 1 (3.6) | 0.389 |
| Statins | 15 (37.5) | 10 (35.7) | 1.000 |